JAMH
IRWD icon

Junson Asset Management (HK)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Junson Asset Management (HK)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-155,277
Closed -$1.66M – 41
2021
Q1 		$1.66M Buy
+155,277
New +$1.64M 0.69% 40

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Junson Asset Management (HK)'s IRWD Position: Q2 2021 in Review

Junson Asset Management (HK) sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 155,277 shares — an estimated $1.66M sold.

Junson Asset Management (HK) first reported a position in IRWD in Q1 2021 and held it in 1 quarter. The position peaked at $1.66M in Q1 2021. 209 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Junson Asset Management (HK) reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Junson Asset Management (HK) sold 155,277 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $1.66M.
  • Junson Asset Management (HK) first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Junson Asset Management (HK)'s Ironwood Pharmaceuticals position peaked at $1.66M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Junson Asset Management (HK)'s 13F filing for Q2 2021, filed 13 Jul 2021.